Clinical Trial Update: Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating safety and efficacy of curcumin in pediatric acute lymphoblastic leukemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia Pediatric

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Ain Shams University | Conditions: Acute Lymphoblastic Leukemia, Pediatric | Phase 2 | Status: COMPLETED